BERWYN, Pa.--(BUSINESS WIRE)--As self-funded employers confront the unprecedented financial and social challenges of the COVID-19 pandemic, AscellaHealth points to its Specialty Medical Rx management services as a critical business ally to work through this historic and devastating time. AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM) serving commercial, Medicare and Medicaid segments, remains committed to supporting employers and their work forces by navigating the complex world of drug pricing and the high-cost of specialty drugs to create effective solutions that curb the total cost of care, increase specialty drug availability and promote patient adherence through appropriate medication therapy management.
To assist with management of the COVID-19 outbreak, AscellaHealth is providing ongoing updates about the numerous vaccines in active development with over 20+ clinical trials underway using various available and investigational drug therapies, including those under investigation by the Chinese government. Many non-clinical trials are also being seen to evaluate potential treatment options.
“Amid the volatility of conducting business in this stressful environment, while ensuring optimal health for employees, employers can turn to AscellaHealth for medication therapy cost containment programs that have a positive impact on budgets during and after the pandemic,” says Dea Belazi, president and CEO, AscellaHealth. “Furthermore, as COVID-19 takes its toll, individuals are often unable to get the medications they need or make regular doctor visits, and adherence to treatment levels is in jeopardy. In this perilous environment, AscellaHealth is there to help and work to avoid unnecessary and potentially deadly hospitalizations.”
AscellaHealth teams of experienced professionals manage patients by driving regimen compliance, enhancing adherence and persistence, speeding time to therapy, reducing patient confusion and improving care coordination communications.
“We are also leveraging the power of telemedicine to connect individuals with care, without exposure to the virus for doctors or patients,” says Belazi. “This is quickly becoming of paramount importance during this public health crisis.”
The AscellaHealth high-touch service model includes: patient and/or caregiver education and training by care coordination teams, beginning on day one; assistance for patients with high deductibles/co-insurance/copay costs by utilizing patient assistance programs and other drug savings programs; and coordination and collaboration with the patient, physician, specialty pharmacy and payer throughout the patient’s course of therapy.
AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.